Mr. Bill Gates acknowledges Hester for developing a Newcastle Disease Vaccine
It gives us immense pride to share with you that Mr. Bill Gates mentioned Hester's name in his speech at AP AgTech Summit 2017 in Visakhapatnam on 17 November 2017.
Mr. Gates referred to the Bill & Melinda Gates Foundation's partnership with Hester in developing a Thermostable Newcastle disease vaccine for the smallholder backyard farmers.
Since 1997, Hester has been manufacturing the conventional Newcastle Disease vaccine, which is required to be stored and transported under a cold chain between 2 to 8 degrees Celsius.
Facilitating mass access to the Newcastle Disease Vaccine in rural backyard poultry farms was therefore always a challenge due to the inability to maintain the cold chain up to the end user of the vaccine.
In 2014, Hester developed a Thermostable Newcastle disease vaccine that withstands a temperature up to 40 degrees Celsius for a few days. This vaccine was developed in collaboration with Galvmed, an international NGO having its head office in Edinburgh, Scotland, funded by the Gates Foundation.
This Thermostable Newcastle disease vaccine is being considered as an appropriate solution to the problem of last-mile-service delivery for backyard farms in rural area where cold-chain infrastructure is available in a compromised form.
YouTube link of the speech of Mr. Bill Gates at The AP AgTech Summit 2017: https://youtu.be/tAacEhTc88k (Hester's name is mentioned in the 9th minute)
Shares of HESTER BIOSCIENCES LTD. was last trading in BSE at Rs.1430 as compared to the previous close of Rs. 1332.75. The total number of shares traded during the day was 11181 in over 1612 trades.
The stock hit an intraday high of Rs. 1467.95 and intraday low of 1355.1. The net turnover during the day was Rs. 15849083.